PT965588E - Processo de preparacao de derivados de 4-fenil-1,2,3,6-tetra-hidropiridina e os produtos intermediarios utilizados no processo - Google Patents

Processo de preparacao de derivados de 4-fenil-1,2,3,6-tetra-hidropiridina e os produtos intermediarios utilizados no processo

Info

Publication number
PT965588E
PT965588E PT99401497T PT99401497T PT965588E PT 965588 E PT965588 E PT 965588E PT 99401497 T PT99401497 T PT 99401497T PT 99401497 T PT99401497 T PT 99401497T PT 965588 E PT965588 E PT 965588E
Authority
PT
Portugal
Prior art keywords
phenyl
reacting
compound
formula
agent
Prior art date
Application number
PT99401497T
Other languages
English (en)
Inventor
Francis Brion
Christian Richard
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of PT965588E publication Critical patent/PT965588E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/42Oxygen atoms attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT99401497T 1998-06-18 1999-06-17 Processo de preparacao de derivados de 4-fenil-1,2,3,6-tetra-hidropiridina e os produtos intermediarios utilizados no processo PT965588E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9807677A FR2780056B1 (fr) 1998-06-18 1998-06-18 Nouveau procede de preparation de derives de la 4-phenyl-1-2 3,6-tetrahydropyridine et les produits imtermediaires mis en oeuvre

Publications (1)

Publication Number Publication Date
PT965588E true PT965588E (pt) 2004-07-30

Family

ID=9527532

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99401497T PT965588E (pt) 1998-06-18 1999-06-17 Processo de preparacao de derivados de 4-fenil-1,2,3,6-tetra-hidropiridina e os produtos intermediarios utilizados no processo

Country Status (11)

Country Link
US (1) US6136981A (pt)
EP (1) EP0965588B1 (pt)
JP (1) JP4538114B2 (pt)
AT (1) ATE261432T1 (pt)
CA (1) CA2275192C (pt)
DE (1) DE69915413T2 (pt)
DK (1) DK0965588T3 (pt)
ES (1) ES2213991T3 (pt)
FR (1) FR2780056B1 (pt)
HU (1) HU225621B1 (pt)
PT (1) PT965588E (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5981747B2 (ja) * 2012-03-28 2016-08-31 東ソー・ファインケム株式会社 アザディールス−アルダー反応用触媒、それを用いたテトラヒドロピリジン化合物の製造方法
CA2982928A1 (en) 2015-04-20 2016-10-27 Tolero Pharmaceuticals, Inc. Predicting response to alvocidib by mitochondrial profiling
EP3298021B1 (en) 2015-05-18 2019-05-01 Tolero Pharmaceuticals, Inc. Alvocidib prodrugs having increased bioavailability
US10568887B2 (en) 2015-08-03 2020-02-25 Tolero Pharmaceuticals, Inc. Combination therapies for treatment of cancer
WO2018094275A1 (en) 2016-11-18 2018-05-24 Tolero Pharmaceuticals, Inc. Alvocidib prodrugs and their use as protein kinase inhibitors
CN110234659A (zh) 2016-12-19 2019-09-13 特雷罗药物股份有限公司 用于敏感性分析的分析肽和方法
US11497756B2 (en) 2017-09-12 2022-11-15 Sumitomo Pharma Oncology, Inc. Treatment regimen for cancers that are insensitive to BCL-2 inhibitors using the MCL-1 inhibitor alvocidib
KR20210099066A (ko) 2018-12-04 2021-08-11 스미토모 다이니폰 파마 온콜로지, 인크. 암의 치료를 위한 작용제로서 사용하기 위한 cdk9 억제제 및 그의 다형체
JP2022525149A (ja) 2019-03-20 2022-05-11 スミトモ ダイニッポン ファーマ オンコロジー, インコーポレイテッド ベネトクラクスが失敗した急性骨髄性白血病(aml)の処置

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2338043A1 (fr) * 1976-01-13 1977-08-12 Delmar Chem Derives de 4-arylpiperidine et procedes de production
US4132710A (en) * 1976-12-20 1979-01-02 Ayerst, Mckenna And Harrison, Ltd. [2]Benzopyrano[3,4-c]pyridines and process therefor
US5849733A (en) * 1996-05-10 1998-12-15 Bristol-Myers Squibb Co. 2-thio or 2-oxo flavopiridol analogs
US6268499B1 (en) * 1998-08-10 2001-07-31 Hoffman-La Roche Inc. Process and intermediates for preparation of substituted piperidine-epoxides

Also Published As

Publication number Publication date
FR2780056B1 (fr) 2000-08-04
ATE261432T1 (de) 2004-03-15
CA2275192C (fr) 2008-12-30
HU225621B1 (en) 2007-05-02
DE69915413D1 (de) 2004-04-15
ES2213991T3 (es) 2004-09-01
HUP9902040A2 (hu) 2001-11-28
HU9902040D0 (en) 1999-08-30
DK0965588T3 (da) 2004-06-21
CA2275192A1 (fr) 1999-12-18
DE69915413T2 (de) 2004-08-19
JP4538114B2 (ja) 2010-09-08
FR2780056A1 (fr) 1999-12-24
EP0965588B1 (fr) 2004-03-10
US6136981A (en) 2000-10-24
EP0965588A1 (fr) 1999-12-22
JP2000026418A (ja) 2000-01-25

Similar Documents

Publication Publication Date Title
AU2570401A (en) New modulators of dopamine neurotransmission
PT923554E (pt) N-benzilpiperidina e derivados tetrahidropiridina
AU3274997A (en) Intermediates for the preparation of duocarmycin sa and derivatives thereof, and process for the production of the intermediates
PT965588E (pt) Processo de preparacao de derivados de 4-fenil-1,2,3,6-tetra-hidropiridina e os produtos intermediarios utilizados no processo
BR9503536A (pt) Composto processo para sua preparação seu uso e composição farmacêutica
FI101376B1 (fi) Menetelmä 3-bentsyyliamino-2-fenyylipiperidiinijohdannaisten valmistamiseksi
RU92016444A (ru) Получение производных пиперидинов и производных пиперидина
PT99978A (pt) Novo composto de amonio quaternario agentes amaciadores nele baseados e processo para a sua preparacao
BR9400016A (pt) Processo para preparação de compostos, e compostos
DK0556813T3 (da) Amfotere tricykliske forbindelser som antihistaminske og antiallergiske midler
PL349933A1 (en) Novel compounds beta-hydroxyalylamides, method of obtaining them and their application
ATE127449T1 (de) Anilinderivate und verfahren zu ihrer herstellung.
DE69007203D1 (de) Imidazolderivate, Verfahren zu deren Herstellung und diese enthaltende Antiulkusmittel.
EP1561744A3 (en) Amine derivatives, process for producing the same and their use as antimycotic agent
AU2306697A (en) Method for producing 3,4-dihydroxy-3-cyclobutene-1,2-dione
AU7589298A (en) 5-{(heteroaryl)alkyl}-3-oxo-pyrido{1,2-(a)}benzimidazole-4-c arboxamide derivatives useful in treating central nervous system disorders
ATE103598T1 (de) Verfahren zur herstellung von zwischenprodukten in der synthese von diltiazem.
AU1866192A (en) New process for the synthesis of enantiomers of 3-aminochroman compounds
IT1276738B1 (it) Processo per la preparazione di derivati dell'acido -metil-2- tiofeneacetico
ES2059275A1 (es) Un procedimiento para producir derivados de acidos grasos halogenofenoxi-sustituidos.